APO Research
Talk to an analyst

APO RESEARCH · REPORT

RGD Peptide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global RGD Peptide Industry Growth and Trends Forecast to 2032

30 December 2025114 pages

Choose your research edition.

Industry ResearchRGD Peptide Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal RGD Peptide Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal RGD Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RGD Peptide Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal RGD Peptide Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global RGD Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RGD Peptide include Wuhan Tanda Biotechnology, XIAN RUIXI, QYAOBIO, TGpeptide, Merck KGaA, Allpeptide, TargetMol Chemicals, Santa Cruz Animal Health and PEPTIDE INSTITUTE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global RGD Peptide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The RGD Peptide market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global RGD Peptide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to RGD Peptide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global RGD Peptide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

RGD Peptide Market by Company

Wuhan Tanda Biotechnology

XIAN RUIXI

QYAOBIO

TGpeptide

Merck KGaA

Allpeptide

TargetMol Chemicals

Santa Cruz Animal Health

PEPTIDE INSTITUTE

Novatein Biosciences

Enzo

Cell Guidance Systems

CD Bioparticles

Bio-Techne

BICO(Advanced BioMatrix)

ApexBio Technology

AnaSpec

Abbiotec

RGD Peptide Segment by Type

RGD Cyclic Peptide

Linear RGD Peptide

RGD Peptide Segment by Application

Pharmaceuticals

Scientific Research

RGD Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RGD Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RGD Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RGD Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RGD Peptide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of RGD Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of RGD Cyclic Peptide Table 2. Major Company of Linear RGD Peptide Table 3. Global RGD Peptide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global RGD Peptide Sales by Type (2021-2026) & (L) Table 5. Global RGD Peptide Sales Market Share in Volume by Type (2021-2026) Table 6. Global RGD Peptide Sales by Type (2021-2026) & (US$ Million) Table 7. Global RGD Peptide Sales Market Share in Value by Type (2021-2026) Table 8. Global RGD Peptide Price by Type (2021-2026) & (US$/mL) Table 9. Global RGD Peptide Sales by Type (2027-2032) & (L) Table 10. Global RGD Peptide Sales Market Share in Volume by Type (2027-2032) Table 11. Global RGD Peptide Sales by Type (2027-2032) & (US$ Million) Table 12. Global RGD Peptide Sales Market Share in Value by Type (2027-2032) Table 13. Global RGD Peptide Price by Type (2027-2032) & (US$/mL) Table 14. North America RGD Peptide Sales by Type (2021-2026) & (L) Table 15. North America RGD Peptide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe RGD Peptide Sales by Type (2021-2026) & (L) Table 17. Europe RGD Peptide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific RGD Peptide Sales by Type (2021-2026) & (L) Table 19. Asia-Pacific RGD Peptide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America RGD Peptide Sales by Type (2021-2026) & (L) Table 21. Latin America RGD Peptide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa RGD Peptide Sales by Type (2021-2026) & (L) Table 23. Middle East and Africa RGD Peptide Sales by Type (2021-2026) & (US$ Million) Table 24. RGD Peptide Industry Trends Table 25. RGD Peptide Industry Drivers Table 26. RGD Peptide Industry Opportunities and Challenges Table 27. RGD Peptide Industry Restraints Table 28. Global RGD Peptide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global RGD Peptide Revenue Market Share by Company (2021-2026) Table 30. Global RGD Peptide Sales by Company (2021-2026) & (L) Table 31. Global RGD Peptide Sales Share by Company (2021-2026) Table 32. Global RGD Peptide Market Price by Company (2021-2026) & (US$/mL) Table 33. Global RGD Peptide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global RGD Peptide Major Company Production Sites and Headquarters Table 35. Global RGD Peptide Company, Product Type & Application Table 36. Global RGD Peptide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global RGD Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global RGD Peptide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global RGD Peptide Sales by Region (2021-2026) & (L) Table 41. Global RGD Peptide Sales Market Share in Volume by Region (2021-2026) Table 42. Global RGD Peptide Sales by Region (2021-2026) & (US$ Million) Table 43. Global RGD Peptide Sales Market Share in Value by Region (2021-2026) Table 44. Global RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 45. Global RGD Peptide Sales by Region (2027-2032) & (L) Table 46. Global RGD Peptide Sales Market Share in Volume by Region (2027-2032) Table 47. Global RGD Peptide Sales by Region (2027-2032) & (US$ Million) Table 48. Global RGD Peptide Sales Market Share in Value by Region (2027-2032) Table 49. Global RGD Peptide Sales (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2027-2032) Table 50. Global RGD Peptide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global RGD Peptide Sales by Application (2021-2026) & (L) Table 52. Global RGD Peptide Sales Market Share in Volume by Application (2021-2026) Table 53. Global RGD Peptide Sales by Application (2021-2026) & (US$ Million) Table 54. Global RGD Peptide Sales Market Share in Value by Application (2021-2026) Table 55. Global RGD Peptide Price by Application (2021-2026) & (US$/mL) Table 56. Global RGD Peptide Sales by Application (2027-2032) & (L) Table 57. Global RGD Peptide Sales Market Share in Volume by Application (2027-2032) Table 58. Global RGD Peptide Sales by Application (2027-2032) & (US$ Million) Table 59. Global RGD Peptide Sales Market Share in Value by Application (2027-2032) Table 60. Global RGD Peptide Price by Application (2027-2032) & (US$/mL) Table 61. North America RGD Peptide Sales by Application (2021-2026) & (L) Table 62. North America RGD Peptide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe RGD Peptide Sales by Application (2021-2026) & (L) Table 64. Europe RGD Peptide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific RGD Peptide Sales by Application (2021-2026) & (L) Table 66. Asia-Pacific RGD Peptide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America RGD Peptide Sales by Application (2021-2026) & (L) Table 68. Latin America RGD Peptide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa RGD Peptide Sales by Application (2021-2026) & (L) Table 70. Middle East and Africa RGD Peptide Sales by Application (2021-2026) & (US$ Million) Table 71. Wuhan Tanda Biotechnology Company Information Table 72. Wuhan Tanda Biotechnology Business Overview Table 73. Wuhan Tanda Biotechnology RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 74. Wuhan Tanda Biotechnology RGD Peptide Product Portfolio Table 75. Wuhan Tanda Biotechnology Recent Development Table 76. XIAN RUIXI Company Information Table 77. XIAN RUIXI Business Overview Table 78. XIAN RUIXI RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 79. XIAN RUIXI RGD Peptide Product Portfolio Table 80. XIAN RUIXI Recent Development Table 81. QYAOBIO Company Information Table 82. QYAOBIO Business Overview Table 83. QYAOBIO RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 84. QYAOBIO RGD Peptide Product Portfolio Table 85. QYAOBIO Recent Development Table 86. TGpeptide Company Information Table 87. TGpeptide Business Overview Table 88. TGpeptide RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 89. TGpeptide RGD Peptide Product Portfolio Table 90. TGpeptide Recent Development Table 91. Merck KGaA Company Information Table 92. Merck KGaA Business Overview Table 93. Merck KGaA RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 94. Merck KGaA RGD Peptide Product Portfolio Table 95. Merck KGaA Recent Development Table 96. Allpeptide Company Information Table 97. Allpeptide Business Overview Table 98. Allpeptide RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 99. Allpeptide RGD Peptide Product Portfolio Table 100. Allpeptide Recent Development Table 101. TargetMol Chemicals Company Information Table 102. TargetMol Chemicals Business Overview Table 103. TargetMol Chemicals RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 104. TargetMol Chemicals RGD Peptide Product Portfolio Table 105. TargetMol Chemicals Recent Development Table 106. Santa Cruz Animal Health Company Information Table 107. Santa Cruz Animal Health Business Overview Table 108. Santa Cruz Animal Health RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 109. Santa Cruz Animal Health RGD Peptide Product Portfolio Table 110. Santa Cruz Animal Health Recent Development Table 111. PEPTIDE INSTITUTE Company Information Table 112. PEPTIDE INSTITUTE Business Overview Table 113. PEPTIDE INSTITUTE RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 114. PEPTIDE INSTITUTE RGD Peptide Product Portfolio Table 115. PEPTIDE INSTITUTE Recent Development Table 116. Novatein Biosciences Company Information Table 117. Novatein Biosciences Business Overview Table 118. Novatein Biosciences RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 119. Novatein Biosciences RGD Peptide Product Portfolio Table 120. Novatein Biosciences Recent Development Table 121. Enzo Company Information Table 122. Enzo Business Overview Table 123. Enzo RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 124. Enzo RGD Peptide Product Portfolio Table 125. Enzo Recent Development Table 126. Cell Guidance Systems Company Information Table 127. Cell Guidance Systems Business Overview Table 128. Cell Guidance Systems RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 129. Cell Guidance Systems RGD Peptide Product Portfolio Table 130. Cell Guidance Systems Recent Development Table 131. CD Bioparticles Company Information Table 132. CD Bioparticles Business Overview Table 133. CD Bioparticles RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 134. CD Bioparticles RGD Peptide Product Portfolio Table 135. CD Bioparticles Recent Development Table 136. Bio-Techne Company Information Table 137. Bio-Techne Business Overview Table 138. Bio-Techne RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 139. Bio-Techne RGD Peptide Product Portfolio Table 140. Bio-Techne Recent Development Table 141. BICO(Advanced BioMatrix) Company Information Table 142. BICO(Advanced BioMatrix) Business Overview Table 143. BICO(Advanced BioMatrix) RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 144. BICO(Advanced BioMatrix) RGD Peptide Product Portfolio Table 145. BICO(Advanced BioMatrix) Recent Development Table 146. ApexBio Technology Company Information Table 147. ApexBio Technology Business Overview Table 148. ApexBio Technology RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 149. ApexBio Technology RGD Peptide Product Portfolio Table 150. ApexBio Technology Recent Development Table 151. AnaSpec Company Information Table 152. AnaSpec Business Overview Table 153. AnaSpec RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 154. AnaSpec RGD Peptide Product Portfolio Table 155. AnaSpec Recent Development Table 156. Abbiotec Company Information Table 157. Abbiotec Business Overview Table 158. Abbiotec RGD Peptide Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 159. Abbiotec RGD Peptide Product Portfolio Table 160. Abbiotec Recent Development Table 161. North America RGD Peptide Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 162. North America RGD Peptide Sales by Country (2021-2026) & (L) Table 163. North America RGD Peptide Sales Market Share by Country (2021-2026) Table 164. North America RGD Peptide Sales Forecast by Country (2027-2032) & (L) Table 165. North America RGD Peptide Sales Market Share Forecast by Country (2027-2032) Table 166. North America RGD Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America RGD Peptide Market Size by Country (2021-2026) & (US$ Million) Table 168. North America RGD Peptide Market Share by Country (2021-2026) Table 169. North America RGD Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America RGD Peptide Market Share Forecast by Country (2027-2032) Table 171. Europe RGD Peptide Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 172. Europe RGD Peptide Sales by Country (2021-2026) & (L) Table 173. Europe RGD Peptide Sales Market Share by Country (2021-2026) Table 174. Europe RGD Peptide Sales Forecast by Country (2027-2032) & (L) Table 175. Europe RGD Peptide Sales Market Share Forecast by Country (2027-2032) Table 176. Europe RGD Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe RGD Peptide Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe RGD Peptide Market Share by Country (2021-2026) Table 179. Europe RGD Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe RGD Peptide Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific RGD Peptide Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific RGD Peptide Sales by Country (2021-2026) & (L) Table 183. Asia-Pacific RGD Peptide Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific RGD Peptide Sales Forecast by Country (2027-2032) & (L) Table 185. Asia-Pacific RGD Peptide Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific RGD Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific RGD Peptide Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific RGD Peptide Market Share by Country (2021-2026) Table 189. Asia-Pacific RGD Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific RGD Peptide Market Share Forecast by Country (2027-2032) Table 191. Latin America RGD Peptide Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 192. Latin America RGD Peptide Sales by Country (2021-2026) & (L) Table 193. Latin America RGD Peptide Sales Market Share by Country (2021-2026) Table 194. Latin America RGD Peptide Sales Forecast by Country (2027-2032) & (L) Table 195. Latin America RGD Peptide Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America RGD Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America RGD Peptide Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America RGD Peptide Market Share by Country (2021-2026) Table 199. Latin America RGD Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America RGD Peptide Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa RGD Peptide Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa RGD Peptide Sales by Country (2021-2026) & (L) Table 203. Middle East and Africa RGD Peptide Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa RGD Peptide Sales Forecast by Country (2027-2032) & (L) Table 205. Middle East and Africa RGD Peptide Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa RGD Peptide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa RGD Peptide Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa RGD Peptide Market Share by Country (2021-2026) Table 209. Middle East and Africa RGD Peptide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa RGD Peptide Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. RGD Peptide Distributors List Table 214. RGD Peptide Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. RGD Peptide Image Figure 2. Global RGD Peptide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RGD Peptide Market Size (2021-2032) & (US$ Million) Figure 4. Global RGD Peptide Sales (2021-2032) & (L) Figure 5. RGD Cyclic Peptide Image Figure 6. Global RGD Cyclic Peptide Sales YoY Growth (2021-2032) & (L) Figure 7. Linear RGD Peptide Image Figure 8. Global Linear RGD Peptide Sales YoY Growth (2021-2032) & (L) Figure 9. Global RGD Peptide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global RGD Peptide Market Share by Type 2025 VS 2032 Figure 11. North America RGD Peptide Sales Market Share in Volume by Type in 2025 Figure 12. North America RGD Peptide Sales Market Share in Value by Type in 2025 Figure 13. Europe RGD Peptide Sales Market Share in Volume by Type in 2025 Figure 14. Europe RGD Peptide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific RGD Peptide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific RGD Peptide Sales Market Share in Value by Type in 2025 Figure 17. Latin America RGD Peptide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America RGD Peptide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa RGD Peptide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa RGD Peptide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 RGD Peptide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceuticals Image Figure 24. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (L) Figure 25. Scientific Research Image Figure 26. Global Scientific Research Sales YoY Growth (2021-2032) & (L) Figure 27. Global RGD Peptide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global RGD Peptide Market Share by Application 2025 VS 2032 Figure 29. North America RGD Peptide Sales Market Share in Volume by Application in 2025 Figure 30. North America RGD Peptide Sales Market Share in Value by Application in 2025 Figure 31. Europe RGD Peptide Sales Market Share in Volume by Application in 2025 Figure 32. Europe RGD Peptide Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific RGD Peptide Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific RGD Peptide Sales Market Share in Value by Application in 2025 Figure 35. Latin America RGD Peptide Sales Market Share in Volume by Application in 2025 Figure 36. Latin America RGD Peptide Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa RGD Peptide Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa RGD Peptide Sales Market Share in Value by Application in 2025 Figure 39. North America RGD Peptide Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 40. North America RGD Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America RGD Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America RGD Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe RGD Peptide Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 44. Europe RGD Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe RGD Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe RGD Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific RGD Peptide Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 48. Asia-Pacific RGD Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific RGD Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific RGD Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America RGD Peptide Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. Latin America RGD Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America RGD Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America RGD Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa RGD Peptide Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Middle East and Africa RGD Peptide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa RGD Peptide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa RGD Peptide Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. RGD Peptide Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. RGD Peptide Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • RGD Cyclic Peptide
  • Linear RGD Peptide
Applications
  • Pharmaceuticals
  • Scientific Research
Companies covered
  • Wuhan Tanda Biotechnology
  • XIAN RUIXI
  • QYAOBIO
  • TGpeptide
  • Merck KGaA
  • Allpeptide
  • TargetMol Chemicals
  • Santa Cruz Animal Health
  • PEPTIDE INSTITUTE
  • Novatein Biosciences
  • Enzo
  • Cell Guidance Systems
  • CD Bioparticles
  • Bio-Techne
  • BICO(Advanced BioMatrix)
  • ApexBio Technology
  • AnaSpec
  • Abbiotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global RGD Peptide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global RGD Peptide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 RGD Peptide Market by Type
  6. 1.3.1 RGD Cyclic Peptide
  7. 1.3.2 Linear RGD Peptide
  8. 1.4 Global RGD Peptide Market Size by Type
  9. 1.4.1 Global RGD Peptide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global RGD Peptide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global RGD Peptide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America RGD Peptide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe RGD Peptide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific RGD Peptide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America RGD Peptide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa RGD Peptide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 RGD Peptide Industry Trends
  2. 2.2 RGD Peptide Industry Drivers
  3. 2.3 RGD Peptide Industry Opportunities and Challenges
  4. 2.4 RGD Peptide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by RGD Peptide Revenue (2021-2026)
  2. 3.2 Global Top Players by RGD Peptide Sales (2021-2026)
  3. 3.3 Global Top Players by RGD Peptide Price (2021-2026)
  4. 3.4 Global RGD Peptide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RGD Peptide Major Company Production Sites & Headquarters
  6. 3.6 Global RGD Peptide Company, Product Type & Application
  7. 3.7 Global RGD Peptide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global RGD Peptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 RGD Peptide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 RGD Peptide Tier 1, Tier 2, and Tier 3
4 RGD Peptide Regional Status and Outlook
  1. 4.1 Global RGD Peptide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global RGD Peptide Historic Market Size by Region
  3. 4.2.1 Global RGD Peptide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global RGD Peptide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global RGD Peptide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global RGD Peptide Forecasted Market Size by Region
  7. 4.3.1 Global RGD Peptide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global RGD Peptide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global RGD Peptide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 RGD Peptide by Application
  1. 5.1 RGD Peptide Market by Application
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Scientific Research
  4. 5.2 Global RGD Peptide Market Size by Application
  5. 5.2.1 Global RGD Peptide Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global RGD Peptide Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global RGD Peptide Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America RGD Peptide Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe RGD Peptide Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific RGD Peptide Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America RGD Peptide Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa RGD Peptide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wuhan Tanda Biotechnology
  2. 6.1.1 Wuhan Tanda Biotechnology Company Information
  3. 6.1.2 Wuhan Tanda Biotechnology Business Overview
  4. 6.1.3 Wuhan Tanda Biotechnology RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Tanda Biotechnology RGD Peptide Product Portfolio
  6. 6.1.5 Wuhan Tanda Biotechnology Recent Developments
  7. 6.2 XIAN RUIXI
  8. 6.2.1 XIAN RUIXI Company Information
  9. 6.2.2 XIAN RUIXI Business Overview
  10. 6.2.3 XIAN RUIXI RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 XIAN RUIXI RGD Peptide Product Portfolio
  12. 6.2.5 XIAN RUIXI Recent Developments
  13. 6.3 QYAOBIO
  14. 6.3.1 QYAOBIO Company Information
  15. 6.3.2 QYAOBIO Business Overview
  16. 6.3.3 QYAOBIO RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 QYAOBIO RGD Peptide Product Portfolio
  18. 6.3.5 QYAOBIO Recent Developments
  19. 6.4 TGpeptide
  20. 6.4.1 TGpeptide Company Information
  21. 6.4.2 TGpeptide Business Overview
  22. 6.4.3 TGpeptide RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 TGpeptide RGD Peptide Product Portfolio
  24. 6.4.5 TGpeptide Recent Developments
  25. 6.5 Merck KGaA
  26. 6.5.1 Merck KGaA Company Information
  27. 6.5.2 Merck KGaA Business Overview
  28. 6.5.3 Merck KGaA RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck KGaA RGD Peptide Product Portfolio
  30. 6.5.5 Merck KGaA Recent Developments
  31. 6.6 Allpeptide
  32. 6.6.1 Allpeptide Company Information
  33. 6.6.2 Allpeptide Business Overview
  34. 6.6.3 Allpeptide RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Allpeptide RGD Peptide Product Portfolio
  36. 6.6.5 Allpeptide Recent Developments
  37. 6.7 TargetMol Chemicals
  38. 6.7.1 TargetMol Chemicals Company Information
  39. 6.7.2 TargetMol Chemicals Business Overview
  40. 6.7.3 TargetMol Chemicals RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 TargetMol Chemicals RGD Peptide Product Portfolio
  42. 6.7.5 TargetMol Chemicals Recent Developments
  43. 6.8 Santa Cruz Animal Health
  44. 6.8.1 Santa Cruz Animal Health Company Information
  45. 6.8.2 Santa Cruz Animal Health Business Overview
  46. 6.8.3 Santa Cruz Animal Health RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Santa Cruz Animal Health RGD Peptide Product Portfolio
  48. 6.8.5 Santa Cruz Animal Health Recent Developments
  49. 6.9 PEPTIDE INSTITUTE
  50. 6.9.1 PEPTIDE INSTITUTE Company Information
  51. 6.9.2 PEPTIDE INSTITUTE Business Overview
  52. 6.9.3 PEPTIDE INSTITUTE RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 PEPTIDE INSTITUTE RGD Peptide Product Portfolio
  54. 6.9.5 PEPTIDE INSTITUTE Recent Developments
  55. 6.10 Novatein Biosciences
  56. 6.10.1 Novatein Biosciences Company Information
  57. 6.10.2 Novatein Biosciences Business Overview
  58. 6.10.3 Novatein Biosciences RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novatein Biosciences RGD Peptide Product Portfolio
  60. 6.10.5 Novatein Biosciences Recent Developments
  61. 6.11 Enzo
  62. 6.11.1 Enzo Company Information
  63. 6.11.2 Enzo Business Overview
  64. 6.11.3 Enzo RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Enzo RGD Peptide Product Portfolio
  66. 6.11.5 Enzo Recent Developments
  67. 6.12 Cell Guidance Systems
  68. 6.12.1 Cell Guidance Systems Company Information
  69. 6.12.2 Cell Guidance Systems Business Overview
  70. 6.12.3 Cell Guidance Systems RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cell Guidance Systems RGD Peptide Product Portfolio
  72. 6.12.5 Cell Guidance Systems Recent Developments
  73. 6.13 CD Bioparticles
  74. 6.13.1 CD Bioparticles Company Information
  75. 6.13.2 CD Bioparticles Business Overview
  76. 6.13.3 CD Bioparticles RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 CD Bioparticles RGD Peptide Product Portfolio
  78. 6.13.5 CD Bioparticles Recent Developments
  79. 6.14 Bio-Techne
  80. 6.14.1 Bio-Techne Company Information
  81. 6.14.2 Bio-Techne Business Overview
  82. 6.14.3 Bio-Techne RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bio-Techne RGD Peptide Product Portfolio
  84. 6.14.5 Bio-Techne Recent Developments
  85. 6.15 BICO(Advanced BioMatrix)
  86. 6.15.1 BICO(Advanced BioMatrix) Company Information
  87. 6.15.2 BICO(Advanced BioMatrix) Business Overview
  88. 6.15.3 BICO(Advanced BioMatrix) RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 BICO(Advanced BioMatrix) RGD Peptide Product Portfolio
  90. 6.15.5 BICO(Advanced BioMatrix) Recent Developments
  91. 6.16 ApexBio Technology
  92. 6.16.1 ApexBio Technology Company Information
  93. 6.16.2 ApexBio Technology Business Overview
  94. 6.16.3 ApexBio Technology RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 ApexBio Technology RGD Peptide Product Portfolio
  96. 6.16.5 ApexBio Technology Recent Developments
  97. 6.17 AnaSpec
  98. 6.17.1 AnaSpec Company Information
  99. 6.17.2 AnaSpec Business Overview
  100. 6.17.3 AnaSpec RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 AnaSpec RGD Peptide Product Portfolio
  102. 6.17.5 AnaSpec Recent Developments
  103. 6.18 Abbiotec
  104. 6.18.1 Abbiotec Company Information
  105. 6.18.2 Abbiotec Business Overview
  106. 6.18.3 Abbiotec RGD Peptide Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Abbiotec RGD Peptide Product Portfolio
  108. 6.18.5 Abbiotec Recent Developments
7 North America by Country
  1. 7.1 North America RGD Peptide Sales by Country
  2. 7.1.1 North America RGD Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America RGD Peptide Sales by Country (2021-2026)
  4. 7.1.3 North America RGD Peptide Sales Forecast by Country (2027-2032)
  5. 7.2 North America RGD Peptide Market Size by Country
  6. 7.2.1 North America RGD Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America RGD Peptide Market Size by Country (2021-2026)
  8. 7.2.3 North America RGD Peptide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe RGD Peptide Sales by Country
  2. 8.1.1 Europe RGD Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe RGD Peptide Sales by Country (2021-2026)
  4. 8.1.3 Europe RGD Peptide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe RGD Peptide Market Size by Country
  6. 8.2.1 Europe RGD Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe RGD Peptide Market Size by Country (2021-2026)
  8. 8.2.3 Europe RGD Peptide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific RGD Peptide Sales by Country
  2. 9.1.1 Asia-Pacific RGD Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific RGD Peptide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific RGD Peptide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific RGD Peptide Market Size by Country
  6. 9.2.1 Asia-Pacific RGD Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific RGD Peptide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific RGD Peptide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America RGD Peptide Sales by Country
  2. 10.1.1 South America RGD Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America RGD Peptide Sales by Country (2021-2026)
  4. 10.1.3 South America RGD Peptide Sales Forecast by Country (2027-2032)
  5. 10.2 South America RGD Peptide Market Size by Country
  6. 10.2.1 South America RGD Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America RGD Peptide Market Size by Country (2021-2026)
  8. 10.2.3 South America RGD Peptide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa RGD Peptide Sales by Country
  2. 11.1.1 Middle East and Africa RGD Peptide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa RGD Peptide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa RGD Peptide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa RGD Peptide Market Size by Country
  6. 11.2.1 Middle East and Africa RGD Peptide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa RGD Peptide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa RGD Peptide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 RGD Peptide Value Chain Analysis
  2. 12.1.1 RGD Peptide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 RGD Peptide Production Mode & Process
  7. 12.2 RGD Peptide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 RGD Peptide Distributors
  10. 12.2.3 RGD Peptide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst